These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38971725)

  • 21. Uptake of three doses of HPV vaccine by primary school girls in Eldoret, Kenya; a prospective cohort study in a malaria endemic setting.
    Mabeya H; Menon S; Weyers S; Naanyu V; Mwaliko E; Kirop E; Orango O; Vermandere H; Vanden Broeck D
    BMC Cancer; 2018 May; 18(1):557. PubMed ID: 29751793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Knowledge, Attitude and Practices Regarding HPV Vaccination Among Medical and Para Medical in Students, India a Cross Sectional Study.
    Swarnapriya K; Kavitha D; Reddy GM
    Asian Pac J Cancer Prev; 2015; 16(18):8473-7. PubMed ID: 26745104
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adapting cervical cancer screening for women vaccinated against human papillomavirus infections: The value of stratifying guidelines.
    Pedersen K; Burger EA; Nygård M; Kristiansen IS; Kim JJ
    Eur J Cancer; 2018 Mar; 91():68-75. PubMed ID: 29335156
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Knowledge and awareness of human papillomavirus infection and human papillomavirus vaccine among Kazakhstani women attending gynecological clinics.
    Issa T; Babi A; Issanov A; Akilzhanova A; Nurgaliyeva K; Abugalieva Z; Azizan A; Khan SA; Chan CK; Alibekova R; Aimagambetova G
    PLoS One; 2021; 16(12):e0261203. PubMed ID: 34898639
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Awareness and Knowledge About HPV and HPV Vaccine Among Romanian Women.
    Grigore M; Teleman SI; Pristavu A; Matei M
    J Cancer Educ; 2018 Feb; 33(1):154-159. PubMed ID: 27830570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Central and Eastern Europe.
    Poljak M; Seme K; Maver PJ; Kocjan BJ; Cuschieri KS; Rogovskaya SI; Arbyn M; Syrjänen S
    Vaccine; 2013 Dec; 31 Suppl 7():H59-70. PubMed ID: 24332298
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [HPV prophylactic vaccine coverage in France: Results of a survey among high school and university students in Marseilles' area].
    Sabiani L; Bremond A; Mortier I; Lecuyer M; Boubli L; Carcopino X
    J Gynecol Obstet Biol Reprod (Paris); 2012 Apr; 41(2):136-44. PubMed ID: 22093439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human papillomavirus prevalence and type-distribution, cervical cancer screening practices and current status of vaccination implementation in Russian Federation, the Western countries of the former Soviet Union, Caucasus region and Central Asia.
    Rogovskaya SI; Shabalova IP; Mikheeva IV; Minkina GN; Podzolkova NM; Shipulina OY; Sultanov SN; Kosenko IA; Brotons M; Buttmann N; Dartell M; Arbyn M; Syrjänen S; Poljak M
    Vaccine; 2013 Dec; 31 Suppl 7():H46-58. PubMed ID: 24332297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Female students receiving post-secondary education in Greece: the results of a collaborative human papillomavirus knowledge survey.
    Michail G; Smaili M; Vozikis A; Jelastopulu E; Adonakis G; Poulas K
    Public Health; 2014 Dec; 128(12):1099-105. PubMed ID: 25443133
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiology of HPV infection and current status of cervical cancer prevention in Greece: final results of the LYSISTRATA cross-sectional study.
    Agorastos T; Chatzistamatiou K; Zafrakas M; Siamanta V; Katsamagkas T; Constantinidis TC; Lampropoulos AF;
    Eur J Cancer Prev; 2014 Sep; 23(5):425-31. PubMed ID: 24977385
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of numerical information on intention to participate in cervical screening among women offered HPV vaccination: a randomised study.
    Hestbech MS; Gyrd-Hansen D; Kragstrup J; Siersma V; Brodersen J
    Scand J Prim Health Care; 2016 Dec; 34(4):401-419. PubMed ID: 27845597
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cervical cancer prevention practices through screening and vaccination: A cross-sectional study among Hong Kong Chinese women.
    Wang LD; Lam WW; Fielding R
    Gynecol Oncol; 2015 Aug; 138(2):311-6. PubMed ID: 26022528
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Investigating Bangladeshi Rural Women's Awareness and Knowledge of Cervical Cancer and Attitude Towards HPV Vaccination: a Community-Based Cross-Sectional Analysis.
    Banik R; Naher S; Rahman M; Gozal D
    J Cancer Educ; 2022 Apr; 37(2):449-460. PubMed ID: 32734448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [HPV prophylactic vaccine coverage and factors impacting its practice among students and high school students in Marseilles' area].
    Baudoin A; Sabiani L; Oundjian F; Tabouret E; Agostini A; Courbière B; Boubli L; Carcopino X
    J Gynecol Obstet Biol Reprod (Paris); 2015 Feb; 44(2):126-35. PubMed ID: 24703591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors associated with HPV vaccination among adult women in Quebec.
    Kiely M; Sauvageau C; Dubé E; Deceuninck G; De Wals P
    Hum Vaccin Immunother; 2013 Jul; 9(7):1421-4. PubMed ID: 23571165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cervical screening with primary HPV testing or cytology in a population of women in which those aged 33 years or younger had previously been offered HPV vaccination: Results of the Compass pilot randomised trial.
    Canfell K; Caruana M; Gebski V; Darlington-Brown J; Heley S; Brotherton J; Gertig D; Jennett CJ; Farnsworth A; Tan J; Wrede CD; Castle PE; Saville M
    PLoS Med; 2017 Sep; 14(9):e1002388. PubMed ID: 28926579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human papillomavirus types in cervical dysplasia among young HPV-vaccinated women: Population-based nested case-control study.
    Kann H; Hortlund M; Eklund C; Dillner J; Faust H
    Int J Cancer; 2020 May; 146(9):2539-2546. PubMed ID: 31868230
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Participation of HPV-Vaccinated Women in a National Cervical Screening Program: Population-Based Cohort Study.
    Herweijer E; Feldman AL; Ploner A; Arnheim-Dahlström L; Uhnoo I; Netterlid E; Dillner J; Sparén P; Sundström K
    PLoS One; 2015; 10(7):e0134185. PubMed ID: 26218492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Exacerbating disparities?: Cervical cancer screening and HPV vaccination.
    Silver MI; Kobrin S
    Prev Med; 2020 Jan; 130():105902. PubMed ID: 31730943
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cervical cancer screening rate differs by HPV vaccination status: An interim analysis.
    Taniguchi M; Ueda Y; Yagi A; Ikeda S; Endo M; Tomimatsu T; Nakayama T; Sekine M; Enomoto T; Kimura T
    Vaccine; 2019 Jul; 37(32):4424-4426. PubMed ID: 31272873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.